Global Medication Market Size, Status and Forecast 2020-2026

May 2020 | 128 pages | ID: GA563E3D525EEN
QYResearch

Abstracts

This report focuses on the global Medication status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Medication development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Pfizer
• Roche
• Sanofi
• Johnson & Johnson
• Merck & Co. (MSD)
• Novartis
• AbbVie
• Gilead Sciences
• GlaxoSmithKline (GSK)
• Amgen
• AstraZeneca
• Bristol-Myers Squibb
• Eli Lilly
• Teva
• Bayer
• Novo Nordisk
• Allergan
• Takeda
• Boehringer Ingelheim
• Takeda

Market segment by Type, the product can be split into

• Brand Drugs
• Generic Drug

Market segment by Application, split into

• Hospital
• Clinic
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Medication status, future forecast, growth opportunity, key market and key players.
• To present the Medication development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Medication are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Medication Revenue
1.4 Market Analysis by Type
  1.4.1 Global Medication Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Brand Drugs
  1.4.3 Generic Drug
1.5 Market by Application
  1.5.1 Global Medication Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Medication Market Perspective (2015-2026)
2.2 Medication Growth Trends by Regions
  2.2.1 Medication Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Medication Historic Market Share by Regions (2015-2020)
  2.2.3 Medication Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Medication Market Growth Strategy
  2.3.6 Primary Interviews with Key Medication Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Medication Players by Market Size
  3.1.1 Global Top Medication Players by Revenue (2015-2020)
  3.1.2 Global Medication Revenue Market Share by Players (2015-2020)
  3.1.3 Global Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Medication Market Concentration Ratio
  3.2.1 Global Medication Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Medication Revenue in 2019
3.3 Medication Key Players Head office and Area Served
3.4 Key Players Medication Product Solution and Service
3.5 Date of Enter into Medication Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Medication Historic Market Size by Type (2015-2020)
4.2 Global Medication Forecasted Market Size by Type (2021-2026)

5 MEDICATION BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Medication Market Size by Application (2015-2020)
5.2 Global Medication Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Medication Market Size (2015-2020)
6.2 Medication Key Players in North America (2019-2020)
6.3 North America Medication Market Size by Type (2015-2020)
6.4 North America Medication Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Medication Market Size (2015-2020)
7.2 Medication Key Players in Europe (2019-2020)
7.3 Europe Medication Market Size by Type (2015-2020)
7.4 Europe Medication Market Size by Application (2015-2020)

8 CHINA

8.1 China Medication Market Size (2015-2020)
8.2 Medication Key Players in China (2019-2020)
8.3 China Medication Market Size by Type (2015-2020)
8.4 China Medication Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Medication Market Size (2015-2020)
9.2 Medication Key Players in Japan (2019-2020)
9.3 Japan Medication Market Size by Type (2015-2020)
9.4 Japan Medication Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Medication Market Size (2015-2020)
10.2 Medication Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Medication Market Size by Type (2015-2020)
10.4 Southeast Asia Medication Market Size by Application (2015-2020)

11 INDIA

11.1 India Medication Market Size (2015-2020)
11.2 Medication Key Players in India (2019-2020)
11.3 India Medication Market Size by Type (2015-2020)
11.4 India Medication Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Medication Market Size (2015-2020)
12.2 Medication Key Players in Central & South America (2019-2020)
12.3 Central & South America Medication Market Size by Type (2015-2020)
12.4 Central & South America Medication Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview and Its Total Revenue
  13.1.3 Pfizer Medication Introduction
  13.1.4 Pfizer Revenue in Medication Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 Roche
  13.2.1 Roche Company Details
  13.2.2 Roche Business Overview and Its Total Revenue
  13.2.3 Roche Medication Introduction
  13.2.4 Roche Revenue in Medication Business (2015-2020)
  13.2.5 Roche Recent Development
13.3 Sanofi
  13.3.1 Sanofi Company Details
  13.3.2 Sanofi Business Overview and Its Total Revenue
  13.3.3 Sanofi Medication Introduction
  13.3.4 Sanofi Revenue in Medication Business (2015-2020)
  13.3.5 Sanofi Recent Development
13.4 Johnson & Johnson
  13.4.1 Johnson & Johnson Company Details
  13.4.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.4.3 Johnson & Johnson Medication Introduction
  13.4.4 Johnson & Johnson Revenue in Medication Business (2015-2020)
  13.4.5 Johnson & Johnson Recent Development
13.5 Merck & Co. (MSD)
  13.5.1 Merck & Co. (MSD) Company Details
  13.5.2 Merck & Co. (MSD) Business Overview and Its Total Revenue
  13.5.3 Merck & Co. (MSD) Medication Introduction
  13.5.4 Merck & Co. (MSD) Revenue in Medication Business (2015-2020)
  13.5.5 Merck & Co. (MSD) Recent Development
13.6 Novartis
  13.6.1 Novartis Company Details
  13.6.2 Novartis Business Overview and Its Total Revenue
  13.6.3 Novartis Medication Introduction
  13.6.4 Novartis Revenue in Medication Business (2015-2020)
  13.6.5 Novartis Recent Development
13.7 AbbVie
  13.7.1 AbbVie Company Details
  13.7.2 AbbVie Business Overview and Its Total Revenue
  13.7.3 AbbVie Medication Introduction
  13.7.4 AbbVie Revenue in Medication Business (2015-2020)
  13.7.5 AbbVie Recent Development
13.8 Gilead Sciences
  13.8.1 Gilead Sciences Company Details
  13.8.2 Gilead Sciences Business Overview and Its Total Revenue
  13.8.3 Gilead Sciences Medication Introduction
  13.8.4 Gilead Sciences Revenue in Medication Business (2015-2020)
  13.8.5 Gilead Sciences Recent Development
13.9 GlaxoSmithKline (GSK)
  13.9.1 GlaxoSmithKline (GSK) Company Details
  13.9.2 GlaxoSmithKline (GSK) Business Overview and Its Total Revenue
  13.9.3 GlaxoSmithKline (GSK) Medication Introduction
  13.9.4 GlaxoSmithKline (GSK) Revenue in Medication Business (2015-2020)
  13.9.5 GlaxoSmithKline (GSK) Recent Development
13.10 Amgen
  13.10.1 Amgen Company Details
  13.10.2 Amgen Business Overview and Its Total Revenue
  13.10.3 Amgen Medication Introduction
  13.10.4 Amgen Revenue in Medication Business (2015-2020)
  13.10.5 Amgen Recent Development
13.11 AstraZeneca
  10.11.1 AstraZeneca Company Details
  10.11.2 AstraZeneca Business Overview and Its Total Revenue
  10.11.3 AstraZeneca Medication Introduction
  10.11.4 AstraZeneca Revenue in Medication Business (2015-2020)
  10.11.5 AstraZeneca Recent Development
13.12 Bristol-Myers Squibb
  10.12.1 Bristol-Myers Squibb Company Details
  10.12.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  10.12.3 Bristol-Myers Squibb Medication Introduction
  10.12.4 Bristol-Myers Squibb Revenue in Medication Business (2015-2020)
  10.12.5 Bristol-Myers Squibb Recent Development
13.13 Eli Lilly
  10.13.1 Eli Lilly Company Details
  10.13.2 Eli Lilly Business Overview and Its Total Revenue
  10.13.3 Eli Lilly Medication Introduction
  10.13.4 Eli Lilly Revenue in Medication Business (2015-2020)
  10.13.5 Eli Lilly Recent Development
13.14 Teva
  10.14.1 Teva Company Details
  10.14.2 Teva Business Overview and Its Total Revenue
  10.14.3 Teva Medication Introduction
  10.14.4 Teva Revenue in Medication Business (2015-2020)
  10.14.5 Teva Recent Development
13.15 Bayer
  10.15.1 Bayer Company Details
  10.15.2 Bayer Business Overview and Its Total Revenue
  10.15.3 Bayer Medication Introduction
  10.15.4 Bayer Revenue in Medication Business (2015-2020)
  10.15.5 Bayer Recent Development
13.16 Novo Nordisk
  10.16.1 Novo Nordisk Company Details
  10.16.2 Novo Nordisk Business Overview and Its Total Revenue
  10.16.3 Novo Nordisk Medication Introduction
  10.16.4 Novo Nordisk Revenue in Medication Business (2015-2020)
  10.16.5 Novo Nordisk Recent Development
13.17 Allergan
  10.17.1 Allergan Company Details
  10.17.2 Allergan Business Overview and Its Total Revenue
  10.17.3 Allergan Medication Introduction
  10.17.4 Allergan Revenue in Medication Business (2015-2020)
  10.17.5 Allergan Recent Development
13.18 Takeda
  10.18.1 Takeda Company Details
  10.18.2 Takeda Business Overview and Its Total Revenue
  10.18.3 Takeda Medication Introduction
  10.18.4 Takeda Revenue in Medication Business (2015-2020)
  10.18.5 Takeda Recent Development
13.19 Boehringer Ingelheim
  10.19.1 Boehringer Ingelheim Company Details
  10.19.2 Boehringer Ingelheim Business Overview and Its Total Revenue
  10.19.3 Boehringer Ingelheim Medication Introduction
  10.19.4 Boehringer Ingelheim Revenue in Medication Business (2015-2020)
  10.19.5 Boehringer Ingelheim Recent Development
13.20 Takeda
  10.20.1 Takeda Company Details
  10.20.2 Takeda Business Overview and Its Total Revenue
  10.20.3 Takeda Medication Introduction
  10.20.4 Takeda Revenue in Medication Business (2015-2020)
  10.20.5 Takeda Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Medication Key Market Segments
Table 2. Key Players Covered: Ranking by Medication Revenue
Table 3. Ranking of Global Top Medication Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Medication Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Brand Drugs
Table 6. Key Players of Generic Drug
Table 7. Global Medication Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Medication Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Medication Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Medication Market Share by Regions (2015-2020)
Table 11. Global Medication Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Medication Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Medication Market Growth Strategy
Table 17. Main Points Interviewed from Key Medication Players
Table 18. Global Medication Revenue by Players (2015-2020) (Million US$)
Table 19. Global Medication Market Share by Players (2015-2020)
Table 20. Global Top Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medication as of 2019)
Table 21. Global Medication by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Medication Product Solution and Service
Table 24. Date of Enter into Medication Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Medication Market Size by Type (2015-2020) (Million US$)
Table 27. Global Medication Market Size Share by Type (2015-2020)
Table 28. Global Medication Revenue Market Share by Type (2021-2026)
Table 29. Global Medication Market Size Share by Application (2015-2020)
Table 30. Global Medication Market Size by Application (2015-2020) (Million US$)
Table 31. Global Medication Market Size Share by Application (2021-2026)
Table 32. North America Key Players Medication Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Medication Market Share (2019-2020)
Table 34. North America Medication Market Size by Type (2015-2020) (Million US$)
Table 35. North America Medication Market Share by Type (2015-2020)
Table 36. North America Medication Market Size by Application (2015-2020) (Million US$)
Table 37. North America Medication Market Share by Application (2015-2020)
Table 38. Europe Key Players Medication Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Medication Market Share (2019-2020)
Table 40. Europe Medication Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Medication Market Share by Type (2015-2020)
Table 42. Europe Medication Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Medication Market Share by Application (2015-2020)
Table 44. China Key Players Medication Revenue (2019-2020) (Million US$)
Table 45. China Key Players Medication Market Share (2019-2020)
Table 46. China Medication Market Size by Type (2015-2020) (Million US$)
Table 47. China Medication Market Share by Type (2015-2020)
Table 48. China Medication Market Size by Application (2015-2020) (Million US$)
Table 49. China Medication Market Share by Application (2015-2020)
Table 50. Japan Key Players Medication Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Medication Market Share (2019-2020)
Table 52. Japan Medication Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Medication Market Share by Type (2015-2020)
Table 54. Japan Medication Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Medication Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Medication Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Medication Market Share (2019-2020)
Table 58. Southeast Asia Medication Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Medication Market Share by Type (2015-2020)
Table 60. Southeast Asia Medication Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Medication Market Share by Application (2015-2020)
Table 62. India Key Players Medication Revenue (2019-2020) (Million US$)
Table 63. India Key Players Medication Market Share (2019-2020)
Table 64. India Medication Market Size by Type (2015-2020) (Million US$)
Table 65. India Medication Market Share by Type (2015-2020)
Table 66. India Medication Market Size by Application (2015-2020) (Million US$)
Table 67. India Medication Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Medication Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Medication Market Share (2019-2020)
Table 70. Central & South America Medication Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Medication Market Share by Type (2015-2020)
Table 72. Central & South America Medication Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Medication Market Share by Application (2015-2020)
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Product
Table 77. Pfizer Revenue in Medication Business (2015-2020) (Million US$)
Table 78. Pfizer Recent Development
Table 79. Roche Company Details
Table 80. Roche Business Overview
Table 81. Roche Product
Table 82. Roche Revenue in Medication Business (2015-2020) (Million US$)
Table 83. Roche Recent Development
Table 84. Sanofi Company Details
Table 85. Sanofi Business Overview
Table 86. Sanofi Product
Table 87. Sanofi Revenue in Medication Business (2015-2020) (Million US$)
Table 88. Sanofi Recent Development
Table 89. Johnson & Johnson Company Details
Table 90. Johnson & Johnson Business Overview
Table 91. Johnson & Johnson Product
Table 92. Johnson & Johnson Revenue in Medication Business (2015-2020) (Million US$)
Table 93. Johnson & Johnson Recent Development
Table 94. Merck & Co. (MSD) Company Details
Table 95. Merck & Co. (MSD) Business Overview
Table 96. Merck & Co. (MSD) Product
Table 97. Merck & Co. (MSD) Revenue in Medication Business (2015-2020) (Million US$)
Table 98. Merck & Co. (MSD) Recent Development
Table 99. Novartis Company Details
Table 100. Novartis Business Overview
Table 101. Novartis Product
Table 102. Novartis Revenue in Medication Business (2015-2020) (Million US$)
Table 103. Novartis Recent Development
Table 104. AbbVie Company Details
Table 105. AbbVie Business Overview
Table 106. AbbVie Product
Table 107. AbbVie Revenue in Medication Business (2015-2020) (Million US$)
Table 108. AbbVie Recent Development
Table 109. Gilead Sciences Business Overview
Table 110. Gilead Sciences Product
Table 111. Gilead Sciences Company Details
Table 112. Gilead Sciences Revenue in Medication Business (2015-2020) (Million US$)
Table 113. Gilead Sciences Recent Development
Table 114. GlaxoSmithKline (GSK) Company Details
Table 115. GlaxoSmithKline (GSK) Business Overview
Table 116. GlaxoSmithKline (GSK) Product
Table 117. GlaxoSmithKline (GSK) Revenue in Medication Business (2015-2020) (Million US$)
Table 118. GlaxoSmithKline (GSK) Recent Development
Table 119. Amgen Company Details
Table 120. Amgen Business Overview
Table 121. Amgen Product
Table 122. Amgen Revenue in Medication Business (2015-2020) (Million US$)
Table 123. Amgen Recent Development
Table 124. AstraZeneca Company Details
Table 125. AstraZeneca Business Overview
Table 126. AstraZeneca Product
Table 127. AstraZeneca Revenue in Medication Business (2015-2020) (Million US$)
Table 128. AstraZeneca Recent Development
Table 129. Bristol-Myers Squibb Company Details
Table 130. Bristol-Myers Squibb Business Overview
Table 131. Bristol-Myers Squibb Product
Table 132. Bristol-Myers Squibb Revenue in Medication Business (2015-2020) (Million US$)
Table 133. Bristol-Myers Squibb Recent Development
Table 134. Eli Lilly Company Details
Table 135. Eli Lilly Business Overview
Table 136. Eli Lilly Product
Table 137. Eli Lilly Revenue in Medication Business (2015-2020) (Million US$)
Table 138. Eli Lilly Recent Development
Table 139. Teva Company Details
Table 140. Teva Business Overview
Table 141. Teva Product
Table 142. Teva Revenue in Medication Business (2015-2020) (Million US$)
Table 143. Teva Recent Development
Table 144. Bayer Company Details
Table 145. Bayer Business Overview
Table 146. Bayer Product
Table 147. Bayer Revenue in Medication Business (2015-2020) (Million US$)
Table 148. Bayer Recent Development
Table 149. Novo Nordisk Company Details
Table 150. Novo Nordisk Business Overview
Table 151. Novo Nordisk Product
Table 152. Novo Nordisk Revenue in Medication Business (2015-2020) (Million US$)
Table 153. Novo Nordisk Recent Development
Table 154. Allergan Company Details
Table 155. Allergan Business Overview
Table 156. Allergan Product
Table 157. Allergan Revenue in Medication Business (2015-2020) (Million US$)
Table 158. Allergan Recent Development
Table 159. Takeda Company Details
Table 160. Takeda Business Overview
Table 161. Takeda Product
Table 162. Takeda Revenue in Medication Business (2015-2020) (Million US$)
Table 163. Takeda Recent Development
Table 164. Boehringer Ingelheim Company Details
Table 165. Boehringer Ingelheim Business Overview
Table 166. Boehringer Ingelheim Product
Table 167. Boehringer Ingelheim Revenue in Medication Business (2015-2020) (Million US$)
Table 168. Boehringer Ingelheim Recent Development
Table 169. Takeda Company Details
Table 170. Takeda Business Overview
Table 171. Takeda Product
Table 172. Takeda Revenue in Medication Business (2015-2020) (Million US$)
Table 173. Takeda Recent Development
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Medication Market Share by Type: 2020 VS 2026
Figure 2. Brand Drugs Features
Figure 3. Generic Drug Features
Figure 4. Global Medication Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Medication Report Years Considered
Figure 9. Global Medication Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Medication Market Share by Regions: 2020 VS 2026
Figure 11. Global Medication Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Medication Market Share by Players in 2019
Figure 14. Global Top Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medication as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Medication Revenue in 2019
Figure 16. North America Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Pfizer Revenue Growth Rate in Medication Business (2015-2020)
Figure 25. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Roche Revenue Growth Rate in Medication Business (2015-2020)
Figure 27. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Sanofi Revenue Growth Rate in Medication Business (2015-2020)
Figure 29. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Johnson & Johnson Revenue Growth Rate in Medication Business (2015-2020)
Figure 31. Merck & Co. (MSD) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Merck & Co. (MSD) Revenue Growth Rate in Medication Business (2015-2020)
Figure 33. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Novartis Revenue Growth Rate in Medication Business (2015-2020)
Figure 35. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. AbbVie Revenue Growth Rate in Medication Business (2015-2020)
Figure 37. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Gilead Sciences Revenue Growth Rate in Medication Business (2015-2020)
Figure 39. GlaxoSmithKline (GSK) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. GlaxoSmithKline (GSK) Revenue Growth Rate in Medication Business (2015-2020)
Figure 41. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Amgen Revenue Growth Rate in Medication Business (2015-2020)
Figure 43. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. AstraZeneca Revenue Growth Rate in Medication Business (2015-2020)
Figure 45. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Bristol-Myers Squibb Revenue Growth Rate in Medication Business (2015-2020)
Figure 47. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Eli Lilly Revenue Growth Rate in Medication Business (2015-2020)
Figure 49. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Teva Revenue Growth Rate in Medication Business (2015-2020)
Figure 51. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Bayer Revenue Growth Rate in Medication Business (2015-2020)
Figure 53. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Novo Nordisk Revenue Growth Rate in Medication Business (2015-2020)
Figure 55. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Allergan Revenue Growth Rate in Medication Business (2015-2020)
Figure 57. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Takeda Revenue Growth Rate in Medication Business (2015-2020)
Figure 59. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Boehringer Ingelheim Revenue Growth Rate in Medication Business (2015-2020)
Figure 61. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Takeda Revenue Growth Rate in Medication Business (2015-2020)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed